Manufacturer or GPO Program year 2020 Source: CMS Open Payments

Pfizer, S.L.

Spain

CMS manufacturer 100000061402

Open in the dashboard

General payments

0 payments

Research payments

$20,000

1 payment

Ownership & investment interest

None reported

Through program year 2020, Pfizer, S.L. reported paying $0 in general payments and $20,000 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$20,000	1

Breakdown

Top research recipients Research payments · program year 2020

Bronx Veterans Medical $20,000 1 payment

Companies with a similar name General payments · program year 2020

Pfizer Inc. NY, United States $513,229,393
Pfizer International LLC NY, United States $1,402,022
Pfizer Pharmaceuticals LLC PR, United States $201,484
Pfizer Chile S.A. Chile $78,355
Pfizer Limited Great Britain (UK) $62,745
Pfizer S.A.S. Colombia $19,741
Pfizer S.A. Peru $18,543
Pfizer Canada Inc Canada $2,036
Pfizer Pharma GMBH Germany $2,030
Pfizer Zona Franca, S.A. Costa Rica $1,395

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 13.

Records

1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.